| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4469759
Max Phase: Preclinical
Molecular Formula: C18H13N5O3S
Molecular Weight: 379.40
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=C(Nc1ccc2c(c1)OCO2)c1cnc(Nc2ccc3[nH]ncc3c2)s1
Standard InChI: InChI=1S/C18H13N5O3S/c24-17(21-12-2-4-14-15(6-12)26-9-25-14)16-8-19-18(27-16)22-11-1-3-13-10(5-11)7-20-23-13/h1-8H,9H2,(H,19,22)(H,20,23)(H,21,24)
Standard InChI Key: JURYXARAJCYLSX-UHFFFAOYSA-N
Associated Targets(Human)
HDQ-P1 (69 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 379.40 | Molecular Weight (Monoisotopic): 379.0739 | AlogP: 3.74 | #Rotatable Bonds: 4 |
| Polar Surface Area: 101.16 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.79 | CX Basic pKa: 2.13 | CX LogP: 2.93 | CX LogD: 2.93 |
| Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.50 | Np Likeness Score: -1.93 |
References
| 1. Rabea SM, Baradaran-Heravi A, Balgi AD, Krause A, Hosseini Farahabadi S, Roberge M, Grierson DS.. (2019) 2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides., 10 (5): [PMID:31097990] [10.1021/acsmedchemlett.8b00610] |
Source
Source(1):